Expression levels of the mitochondrial IAP antagonists Smac/DIABLO and Omi/HtrA2 in clear-cell renal cell carcinomas and their prognostic value (Q46961534)

From Wikidata

Jump to navigation Jump to search

scientific article published on 9 October 2007

Language	Label	Description	Also known as
English	Expression levels of the mitochondrial IAP antagonists Smac/DIABLO and Omi/HtrA2 in clear-cell renal cell carcinomas and their prognostic value	scientific article published on 9 October 2007

Statements

scholarly article

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17922292

Expression levels of the mitochondrial IAP antagonists Smac/DIABLO and Omi/HtrA2 in clear-cell renal cell carcinomas and their prognostic value (English)

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17922292

author name string

Carsten Kempkensteffen

1

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17922292

Stefan Hinz

2

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17922292

Frank Christoph

3

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17922292

Hans Krause

4

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17922292

Ahmed Magheli

5

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17922292

Mark Schrader

6

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17922292

Martin Schostak

7

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17922292

Kurt Miller

8

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17922292

Steffen Weikert

9

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17922292

publication date

9 October 2007

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17922292

Journal of Cancer Research and Clinical Oncology

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17922292

134

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17922292

5

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17922292

543-550

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17922292

https://scigraph.springernature.com/pub.10.1007/s00432-007-0317-7

0 references

Renal-Cell Carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17922292

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The inhibitors of apoptosis (IAPs) and their emerging role in cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17922292

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Renal-cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17922292

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

SMAC negatively regulates the anti-apoptotic activity of melanoma inhibitor of apoptosis (ML-IAP)

1 reference

https://pubmed.ncbi.nlm.nih.gov/17922292

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dysregulation of apoptosis in cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17922292

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic indicators for renal cell carcinoma: a multivariate analysis of 643 patients using the revised 1997 TNM staging criteria

1 reference

https://pubmed.ncbi.nlm.nih.gov/17922292

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Direct interaction between survivin and Smac/DIABLO is essential for the anti-apoptotic activity of survivin during taxol-induced apoptosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17922292

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantification of mRNA by polymerase chain reaction (PCR) using an internal standard and a nonradioactive detection method

1 reference

https://pubmed.ncbi.nlm.nih.gov/17922292

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The inhibitor of apoptosis protein family (IAPs): an emerging therapeutic target in cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17922292

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Death and anti-death: tumour resistance to apoptosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17922292

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patterns of failure following surgical resection of renal cell carcinoma: implications for adjuvant local and systemic therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/17922292

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cell death regulation by the mammalian IAP antagonist Diablo/Smac.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17922292

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidemiologic aspects of renal cell cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17922292

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/17922292

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Downregulation of Smac/DIABLO expression in renal cell carcinoma and its prognostic significance.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17922292

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

IAP family proteins--suppressors of apoptosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17922292

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of Smac/DIABLO is a novel prognostic marker in lung cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17922292

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Livin promotes Smac/DIABLO degradation by ubiquitin-proteasome pathway

1 reference

https://pubmed.ncbi.nlm.nih.gov/17922292

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adjuvant treatment for renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17922292

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A new protocol for the followup of renal cell carcinoma based on pathological stage

1 reference

https://pubmed.ncbi.nlm.nih.gov/17922292

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Caspases: the proteases of the apoptotic pathway

1 reference

https://pubmed.ncbi.nlm.nih.gov/17922292

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

IAP proteins: blocking the road to death's door

1 reference

https://pubmed.ncbi.nlm.nih.gov/17922292

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of Omi/HtrA2 as a mitochondrial apoptotic serine protease that disrupts inhibitor of apoptosis protein-caspase interaction

1 reference

https://pubmed.ncbi.nlm.nih.gov/17922292

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin-2 in combination with interferon-alpha and 5-fluorouracil for metastatic renal cell cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17922292

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunohistochemical analysis of Smac/DIABLO expression in human carcinomas and sarcomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/17922292

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cryotherapy: clinical end points and their experimental foundations

1 reference

https://pubmed.ncbi.nlm.nih.gov/17922292

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Disturbed balance of expression between XIAP and Smac/DIABLO during tumour progression in renal cell carcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/17922292

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Novel link between E2F1 and Smac/DIABLO: proapoptotic Smac/DIABLO is transcriptionally upregulated by E2F1.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17922292

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition

1 reference

https://pubmed.ncbi.nlm.nih.gov/17922292

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improved prognostication of renal cell carcinoma using an integrated staging system

1 reference

https://pubmed.ncbi.nlm.nih.gov/17922292

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression and genetic analysis of XIAP-associated factor 1 (XAF1) in cancer cell lines

1 reference

https://pubmed.ncbi.nlm.nih.gov/17922292

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of adjuvant therapy in non-metastatic RCC.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17922292

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endogenous inhibitors of caspases

1 reference

https://pubmed.ncbi.nlm.nih.gov/17922292

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Validation of an integrated staging system toward improved prognostication of patients with localized renal cell carcinoma in an international population

1 reference

https://pubmed.ncbi.nlm.nih.gov/17922292

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The changing natural history of renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17922292

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reaper eliminates IAP proteins through stimulated IAP degradation and generalized translational inhibition

1 reference

https://pubmed.ncbi.nlm.nih.gov/17922292

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The anti-apoptotic activity of XIAP is retained upon mutation of both the caspase 3- and caspase 9-interacting sites

1 reference

https://pubmed.ncbi.nlm.nih.gov/17922292

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Follow-up guidelines for nonmetastatic renal cell carcinoma based on the occurrence of metastases after radical nephrectomy

1 reference

https://pubmed.ncbi.nlm.nih.gov/17922292

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of XAF1 as an antagonist of XIAP anti-Caspase activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/17922292

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stage specific guidelines for surveillance after radical nephrectomy for local renal cell carcinoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17922292

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neutralization of Smac/Diablo by inhibitors of apoptosis (IAPs). A caspase-independent mechanism for apoptotic inhibition

1 reference

https://pubmed.ncbi.nlm.nih.gov/17922292

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00432-007-0317-7

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17922292

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17922292

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46961534&oldid=2139746008"